PulseCheck” is a series within CardiaCast that is designed for Cardiovascular (CV) Team members who are new, or new to ...

In this week’s View, Dr. Eagle looks at the consequences of discontinuing long-term drug treatment in patients with heart ...

Can algorithms improve the management of patients with myocardial injury? Is there a tool to aid diagnosing patients faster ...

Welcome to the Cardiovascular (CV) Dyad Leadership Strategic Planning Series! In episode two of four, Dr. Tom Draper talks with Mr. Adam DeJong and Dr. Malissa Wood about efforts required in the ...

Participation in ACC’s Reduce the Risk: PCI Bleed Campaign was associated with a significant reduction of bleeding events following PCI, according to a study published in Circulation: Cardiovascular ...

Wolfe NK, Schiff MD, Christopher AB, et al., on behalf of FORCE Investigators. The study made use of the FORCE (Fontan Outcomes Registry Using CMR Examinations) registry, which collects clinical and ...

Findings from the TAVR UNLOAD trial found preemptive TAVR was not superior to clinical aortic stenosis surveillance (CASS) for the hierarchical occurrence of all-cause death, disabling stroke, disease ...

The Centers for Medicare and Medicaid Services (CMS) released the 2025 Medicare Physician Fee Schedule (PFS) final rule and the 2025 Hospital Outpatient Prospective Payment System (OPPS) and ...

Tetralogy of Fallot is the most common cyanotic congenital heart disease and requires surgical repair. Strategy and timing/type of intervention is variable and depends on clinical symptomatology and ...

A biodegradable polymer sirolimus-eluting stent (BP-SES) was noninferior to currently-used second-generation drug-eluting stents (DES) in terms of target lesion failure (TLF) at one year in patients ...